Pay in 4 interest-free payments of $7.25 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Modern sulphonylureas and cardiovascular adverse effects: will CAROLINA put an end to the controversy
Acta Pharmacol Sin 2003
Several licensed weight management injectable therapies are available in the UK including semaglutide (Wegovy, approved by NICE for weight management in eligible adults) and tirzepatide (Mounjaro, licensed in the UK for type 2 diabetes and, subject to current NICE guidance, for weight management in eligible adults)
Antihistamines to use with caution or avoid: Hydroxyzine and mizolastine should be avoided where possible in patients taking escitalopram due to the combined QT prolongation risk
US$ 26.02
US$ 20.71
US$ 27.52
US$ 20.64
US$ 23.36
US$ 24.04
US$ 21.68
